Pharmacy data, brought into focus

A unified data intelligence and analytics infrastructure that brings transparency and clarity to pharmacy data.

Pharmacy data today is fragmented and delayed, limiting visibility into patient access and leaving life sciences companies without clear insight into access gaps, performance changes, or why prescriptions stall. 

Partial stories, partial results: the pitfalls of fragmented data

“The drug is great but hard to get for patients.”

When HCP feedback signals access friction, fragmented and delayed pharmacy data makes it difficult to determine if prescriptions are stalling due to workflow burden, coverage barriers, or pharmacy availability.

For emerging life sciences companies, early success depends on more than just demand generation.

“I am losing money on these prescriptions.”

When pharmacy feedback signals margin pressure, fragmented and delayed pharmacy data conceals whether margin erosion is due to reimbursement gaps, inventory risk, or operational burden.

As a mid-sized pharma company scales its programs, affordability constraints collide with pharmacy economics, resulting in reduced fill priority, shrinking availability, and slower program responsiveness.

“It took over a month to get my medicine.”

When patient feedback signals therapy initiation is stalling at scale, fragmented and delayed pharmacy data makes it difficult to determine whether the issue stems from payor barriers, healthcare provider lag, pharmacy operational backlogs, logistics breakdowns, or inadequate on hand inventory.

For large pharma, hidden inefficiencies accumulate, making access preservation critical to maintain competitive advantage and market share.

content-sticky-bg

Introducing statusOneTM: A pharmacy-first platform for pharma insights

Unified data from your pharmacies

statusOne creates a pharmacy to pharma data layer — standardizing definitions, metrics, and performance signals at the source so life sciences can finally see what’s happening across the full medication access journey.

Get started

one-pharmacy-data-layer
Measurable, scalable Intelligence

Built on the statusOne data foundation, data is translated into actionable insight — revealing where access breaks down, and where intervention will actually move outcomes.

Next steps

statusone-nrx-funnel
When data becomes interactive.

With data and intelligence in place, statusOne operationalizes insights into conversations, empowering teams to dig deeper into pharmacy performance data, surface patterns at scale, and uncover the “why” behind the outcomes.

Reach out

statusone-agent

Data management is not our core competency, and frankly, we are struggling. Keeping up with data quality standards while responding to manufacturers’ constantly changing needs and questions is overwhelming. status70’s product addresses an unmet need we didn’t even realize we could solve.

VP, Operations at a Specialty Pharmacy

Our commercial ops teams are drowning in Excel spreadsheets and custom Tableau builds just to understand pharmacy data. Our data aggregator falls short on insights and standardization. The industry is overdue for a dedicated manufacturer to pharmacy analytics layer.

Sr. Director, Commercial Operations and Analytics at a Mid-Sized Pharma Company

Business reviews always ask the same questions: patient drop-off, coverage denials, forecast pacing. My team spends hours reconciling data for answers. We need analytics that surface the ‘why’ in real-time, not after the meeting.

Executive Director, Patient Support & Distribution, Large Pharmaceutical Company

Data management is not our core competency, and frankly, we are struggling. Keeping up with data quality standards while responding to manufacturers’ constantly changing needs and questions is overwhelming. status70’s product addresses an unmet need we didn’t even realize we could solve.

VP, Operations at a Specialty Pharmacy

Our commercial ops teams are drowning in Excel spreadsheets and custom Tableau builds just to understand pharmacy data. Our data aggregator falls short on insights and standardization. The industry is overdue for a dedicated manufacturer to pharmacy analytics layer.

Sr. Director, Commercial Operations and Analytics at a Mid-Sized Pharma Company

Business reviews always ask the same questions: patient drop-off, coverage denials, forecast pacing. My team spends hours reconciling data for answers. We need analytics that surface the ‘why’ in real-time, not after the meeting.

Executive Director, Patient Support & Distribution, Large Pharmaceutical Company

Let’s talk

Bring your pharmacy data into focus.

Contact